Politiques du care et gouvernement de la vie: Une typologie des pratiques locales en Suisse

Le concept de « care » rend compte des activités et des relations relatives à la prise en charge des situations de dépendance (petite enfance, personnes âgées, handicap). Sur la base du cas Suisse, cet article soutient que les politiques locales du care participent à une forme de gouvernement de la vie. Dans la première partie, théorique, je propose de rattacher le care aux théories contemporaines sur le biopouvoir, en tant que mode de régulation de la vie dans sa dimension sociale; puis, je présente un cadre d'analyse du care permettant la comparaison des politiques publiques concrètes du care comme biopolitiques. Dans une seconde partie, empirique, je compare six politiques locales menées en Suisse. Cette analyse permet de mettre en évidence trois types idéaux de gouvernement de la vie et d'en discuter les implications normatives.     

Enduring,ephemeral and emerging issues in public administration in Canada: Trends in Canadian Public Administration over fifty years (1958–2007)

Abstract: This issue of Canadian Public Administration marks two landmarks. It is the 50th anniversary issue of the Journal, and it is the last issue to be published by the Institute of Public Administration of Canada. For this issue, we have not produced a “special issue” in the sense of commissioning particular articles. Instead, we have brought together a number of articles that were already in the “pipeline” but that the editors thought made a particular contribution to public administration in Canada. This introductory article, or editor's review, is a retrospective analysis of the content of the Journal. It would appear that while there has been a slight shift towards public policy and a greater concern with provincial and local administration, cpa has maintained an enduring interest in its core areas of administrative theory and political and legal institutions. The content is also compared with findings of the content of other journals and also other analyses of cpa . This review is followed by commentaries by former editors and associate editors on their experiences with the Journal.     

Orphan drug incentives in the pharmacogenomic context: policy responses in the US and Canada

Advances in pharmacogenomic research and increasing industry interest in personalized medicine have important implications for the way that orphan drug policies are interpreted and applied. Concerns have been raised about the potential impact of pharmacogenomics and new genomic technologies on our understanding of how disease categories are delineated, and subsequently, how the concept of rare disease should be defined for the purposes of orphan drug policies. This article considers whether orphan drug legislation can be drafted in a way that will maximize benefits and minimize concerns relating to the impact of pharmacogenomics on orphan drug research and development. After reviewing the issues that may arise at the intersection of orphan drug policies and pharmacogenomics, this article will discuss the potential impact of pharmacogenomics at two critical points: orphan designation and approval of the drug product. At each of these points, the relevant aspects of current US orphan drug legislation are examined, focusing on the extent to which recent amendments may address concerns that have been raised previously. This analysis will then provide the foundation for a critical review and recommendations regarding the proposed new Canadian orphan drug framework.